HHLR ADVISORS, LTD.
Long book
$1.67B
Q1 2026
Positions
38
Top-10 weight
94%
concentration
Last quarter
-3.2%
SPY +14.8%
Turnover
31%
of book per quarter
Strategy in plain words
auto-generated from filingsHHLR ADVISORS, LTD. is a concentrated fundamental stock-picker, running a $1.67B US long book across 38 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: PDD HOLDINGS INC, ALIBABA GROUP HOLDING-SP ADR, BEONE MEDICINES LTD-ADR, FUTU HOLDINGS LTD-ADR, LEGEND BIOTECH CORP-ADR.
Over the last 9 quarters its long book ran on average 1.5pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+1.3%
Q2 2024
+23.8%
Q3 2024
-16.8%
Q4 2024
+25.7%
Q1 2025
-0.3%
Q2 2025
+24.4%
Q3 2025
-16.7%
Q4 2025
-11.6%
Q1 2026
-3.2%
Sector allocation
Healthcare 81%
Technology 11%
Financials 4%
Industrials 2%
Materials 1%
Other 1%
Long book by quarter
What does HHLR ADVISORS, own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| AVBP ARRIVENT BIOPHARMA INC | Healthcare | 3.9M | $90.6M | 5.4% | Held |
| CTKB CYTEK BIOSCIENCES INC | Healthcare | 6.7M | $29.1M | 1.7% | Held |
| MRVL MARVELL TECHNOLOGY INC | Technology | 171.0K | $16.9M | 1.0% | New |
| MAZE MAZE THERAPEUTICS INC | Healthcare | 366.0K | $10.9M | 0.7% | -20.0% |
| CTNM CONTINEUM THERAPEUTICS INC-A | Healthcare | 669.3K | $8.7M | 0.5% | Held |
| BULL WEBULL CORP | Financials | 1.5M | $7.2M | 0.4% | -74.9% |
| SGMT SAGIMET BIOSCIENCES INC-A | Healthcare | 724.8K | $3.8M | 0.2% | Held |
| GE GENERAL ELECTRIC | Industrials | 10.0K | $2.8M | 0.2% | Held |
| GOSS GOSSAMER BIO INC | Healthcare | 5.0M | $1.6M | 0.1% | Held |
| INTC INTEL CORP | Technology | 29.0K | $1.3M | 0.1% | New |
| PACB PACIFIC BIOSCIENCES OF CALIF | Healthcare | 918.9K | $1.2M | 0.1% | Held |
| EQX EQUINOX GOLD CORP | Materials | 80.5K | $1.2M | 0.1% | Held |
| NVDA NVIDIA CORP | Technology | 6.6K | $1.2M | 0.1% | New |
| LITE LUMENTUM HOLDINGS INC | Technology | 1.5K | $1.1M | 0.1% | New |
| GLW CORNING INC | Industrials | 7.7K | $1.0M | 0.1% | New |
| B BARRICK MINING CORP | Materials | 25.4K | $1.0M | 0.1% | Held |
| COHR COHERENT CORP | Other | 4.3K | $1.0M | 0.1% | New |
| ALGS ALIGOS THERAPEUTICS INC | Healthcare | 76.2K | $567K | 0.0% | Held |
| RDGT RIDGETECH INC | Healthcare | 20.2K | $657 | 0.0% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 38 | $1.67B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 33 | $3.10B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 33 | $4.09B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 36 | $3.10B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 49 | $3.54B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 45 | $2.89B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 48 | $4.56B | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 78 | $4.05B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 63 | $4.60B | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP